Search results
Results from the WOW.Com Content Network
A study of more than 6 million Danes published in JAMA Psychiatry in May found that people who have cannabis use disorder (meaning, they’re unable to stop using marijuana) had a higher risk of ...
To assess how marijuana affects people's mental health, Charlie Health looked at the numbers, including data on how cannabis use is linked to psychosis, depression, and other mental health ...
A 2017 review suggests that cannabis has been shown to improve the mood of depression-diagnosed patients. [12] This is indicative of a longitudinal relationship between cannabis reduction and improvements in anxiety and depression. Anxiety and depression have been found to increase susceptibility to marijuana use. [52]
Although scientists are still learning about the effects of marijuana on developing brains, studies so far suggest marijuana use in teenagers may affect functions such as attention, memory and ...
The psychoactive component of cannabis, tetrahydrocannabinol (THC) is not effective in treating emotion-regulation and anxiety-related symptoms. [20] Conversely, THC has been empirically related to an increase anxiety symptoms through impacts on neurological areas impacting serotonin, noradrenalin, GABA and glutamate.
Legal cannabis (marijuana) product. Overconsumption and reliance could lead to cannabis-induced amotivational syndrome. The term amotivational syndrome was first devised to understand and explain the diminished drive and desire to work or compete among the population of youth who are frequent consumers of cannabis and has since been researched through various methodological studies with this ...
Weed affects your ability to make decisions, control emotions, remember important data, plan, organize and solve problems, a new study found, and that impact may last well past your initial high.
For the treatment of the withdrawal/negative affect symptom domain of cannabis use disorder, medications may work by alleviating restlessness, irritable or depressed mood, anxiety, and insomnia. [58] Bupropion, which is a norepinephrine–dopamine reuptake inhibitor, has been studied for the treatment of withdrawal with largely poor results. [58]